Navigation Links
Cancer studies warn over NHS cost-cutting
Date:1/15/2012

A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS.

University of Leicester researcher Professor Paul Symonds also highlights the risk of jeopardizing this record of success if measures to become more cost effective are not carefully thought through and implemented.

In two papers published this month in the journal Clinical Oncology, Professor Paul Symonds of the Department of Cancer Studies and Molecular Medicine, assesses attitudes and beliefs concerning cancer care in the UK.

In one paper, Professor Symonds, who is also a consultant at Leicester's Hospitals, and researcher Karen Lord highlight the importance of closer clinical relationships between physicians and cancer patients in helping patients cope with both treatment and diagnosis.

He said: "It is widely accepted that low trust between a cancer patient and their doctor can influence treatment outcome. The good news is that in Leicester we have found a very high level of trust in both hospital and primary care doctors. We must, however, understand the needs of particular patients when sharing sensitive information about the disease and treatment in order to maintain this trust."

Professor Symonds research, funded by Hope Against Cancer, measured trust in healthcare professionals amongst ethnically diverse cancer patients and assessed the effect of this trust on the patients' ability to cope when diagnosed with cancer.

Between September 2007 and January 2010, 279 patients, who were aware they had cancer, entered the study at the Leicestershire Cancer Centre. Researchers found that there was a high level of trust in local hospital doctors in both groups with a confidence that hospital doctors would give the best possible treatment. Researchers also found that:

  • Over 90% of patients regarded their hospital doctors as honest, competent and caring.
  • A greater understanding by the patient of their illness is a strong predictor of trust.
  • The British South Asian community had slightly less trust in their GPs but still preferred the general practitioner to be the key communicator of sensitive information.
  • Those who did not have this level of trust and had more symptoms of depression were less sure that doctors always listened to their concerns.
  • Women and depressed patients had a higher preference for seeing doctors of the same gender with Asian women being more particular on this matter.
  • More patients among the British South Asian community wished to receive sensitive information from someone of a similar religion or background.

Professor Symonds warned against the effect of NHS cost cutting eroding patient trust as has been observed in the USA.

"As we enter an age of austerity we must do our best to preserve this very high level of trust among cancer patients," urged Professor Symonds. "Clearly it is important that cost rather than cost-effectiveness should not be an overriding factor in cancer treatment to assure the highest level of success and hospital doctors and GPs must work in a partnership to meet the needs of the patient."

In a separate study also published in the same journal the Leicester researchers compared knowledge about the outcome of cancer treatment and beliefs about the causes of cancer among British South Asian cancer patients and beliefs held by British White cancer patients and the impact of these beliefs upon the patients' mental health.

The vast majority believed cancer to be curable, with only 10.6% of the British South Asian group and 2.7% of the British White group thinking it was incurable. Out of the total sample, 93% understood the advantages of early screening.

The way patients understand cancer can have a major impact on how they cope with it psychologically. This study is part of a wider investigation with the long-term aim of improving psychological support of cancer patients.


'/>"/>

Contact: Paul Symonds
paul.symonds@uhl-tr.nhs.uk
44-116-258-6294
University of Leicester
Source:Eurekalert

Related medicine news :

1. Researchers use sugar to halt esophageal cancer in its tracks
2. Predicting the value of indexing symptoms for ovarian cancer
3. Experts Urge Public Action to Aid Cancer Prevention
4. Does Deodorant Ingredient Affect Breast Cancer Risk?
5. Cabazitaxel with radiation and hormone therapy may improve prostate cancer survival
6. UNC scientists collaborate to find first major genetic mutation associated with hereditary prostate cancer risk
7. Scientists Identify Inherited Prostate Cancer Gene
8. Cancer sequencing project identifies potential approaches to combat aggressive leukemia
9. Tests Might Someday Help Spot Early Lung Cancer
10. Updated American Cancer Society nutrition guidelines stress need for supportive environment
11. Lab-made tissue picks up the slack of Petri dishes in cancer research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: